CAPITALHILL ADVISORY for MERCK SHARP & DOHME
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Australian government policy on intellectual property and its impact on the Australian healthcare system
Foreign entity interest: Australian Government Impact of policy on the company's local business environment
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL | — |
Pharmacy PHA
Australian government policy on intellectual property and its impact on the Australian healthcare system
Foreign entity interest: Australian Government Impact of policy on the company's local business environment
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL | — |
Trade (domestic/foreign) TRD
Australian government policy on intellectual property and its impact on the Australian healthcare system
Foreign entity interest: Australian Government Impact of policy on the company's local business environment
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL | — |
Copyright/Patent/Trademark CPT
Australian government policy on intellectual property and its impact on the Australian healthcare system
Foreign entity interest: Australian Government Impact of policy on the company's local business environment
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICHOLAS CAMPBELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.